Manuka honey market seen reaching $776.4M by 2031

The global manuka honey market is projected to grow from $455.4 million in 2021 to $776.4 million by 2031, driven by health-conscious consumers, expanding uses in food and pharmaceuticals, and stronger demand in Europe and Asia-Pacific. Allied Market Research says the market will rise at a 5.5% CAGR from 2022 to 2031.

Why it matters: - Manuka honey is moving beyond a specialty food into health supplements, nutraceuticals, pharmaceuticals and personal care. - The market’s projected rise to $776.4 million by 2031 signals continued demand for products tied to wellness and wound care. - Europe’s lead and Asia-Pacific’s faster growth point to where brands and retailers may see the biggest commercial opportunities.

What happened: - Allied Market Research valued the global manuka honey market at $455.4 million in 2021. - The firm projects the market will reach $776.4 million by 2031. - The forecast calls for a 5.5% CAGR from 2022 to 2031. - The report was published June 5, 2026. - The release included a sample report, a purchase inquiry page, and links to related reports on the organic honey market, dried honey market, and honey wine market.

The details: - The report cites western cultural influence, rapid urbanization, changing views on alcohol-based food products, and shifting consumer preferences in developing regions as growth drivers. - The report also points to rising millennial demand as a new market opportunity. - Consumers with less time for diet management are increasingly choosing manuka honey supplements to support nutritional needs. - Health benefits remain the main marketing hook for manuka honey products. - Manuka honey is used widely in Europe and North America, followed by Asia-Pacific. - The report lists product examples including organic manuka honey, Comvita UMF 5+ manuka honey, Manuka Doctor, monofloral manuka honey, MGO 925+, 8.75 oz (250 g), and Nelson honey manuka honey multi floral. - Growth in manuka honey powder use in food and beverages and pharmaceuticals is also boosting demand. - The report says manuka honey’s disease-preventing properties are expanding use in pharmaceuticals and nutraceuticals. - Research cited in the release says manuka honey has antibacterial and anti-inflammatory properties and has been used to treat wounds. - The release says methylglyoxal, flavonoids and phenolic chemicals in manuka honey may support wound healing and therapeutic uses. - The market is segmented by type into UMF 5+, UMF 10+, UMF 15+ and UMF 20+. - The market is segmented by nature into organic/natural and conventional. - The market is segmented by application into food and beverages, cosmetic and personal care, nutraceutical, pharmaceutical and others. - Food and beverages is further broken into beverages, dairy products, bakery and confectionery, and others. - The regional analysis covers North America, Europe, Asia-Pacific and LAMEA.

Between the lines: - The report frames manuka honey as a wellness product first, not just a sweetener. - Product differentiation appears to be centered on potency labels, organic positioning and cross-category uses. - Europe’s lead suggests mature demand, while Asia-Pacific’s faster CAGR suggests more room for expansion. - The mention of close substitutes and innovation in ice cream indicates competitive pressure from adjacent food categories.

What’s next: - Europe is expected to remain the largest market in 2031 at $296.6 million, according to the forecast. - Asia-Pacific is projected to grow fastest, at 6.1% CAGR. - The report expects rising urban populations, higher disposable income and better living standards to support further growth. - Market competition will likely continue among companies including Manukora, Comvita, Arataki Honey, Egmont Honey, Manuka Pharm, Manuka Doctor, Airbone Honey, Wedderspoon Organic, Steens Honey, Happy Valley Honey, WildCape Manuka Honey, Midlands Apiaries, New Zealand Honey Co, Three Peaks Manuka Honey and Manuka Lab.

The bottom line: - Manuka honey’s growth story is being driven by health demand, broader industrial use and strong regional momentum, with Europe still in front and Asia-Pacific catching up fast.